Drug Trial Radar · NCT07712913
Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia
Last checked: Nov 20, 2026Latest source record: Jul 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
348
Planned (sponsor's estimate)
Start
Jun 18, 2026
Primary completion
Jun 1, 2027
Study completion Jun 1, 2027
Sponsor
- Lead sponsor
- Brainfarma Industria Química e Farmacêutica S/AIndustry
- Sponsor type
- Industry
- First posted
- Jul 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia
Conditions
- Diabetic Neuropathy
- Neuropathic Pain
- Neuralgia, Postherpetic
Interventions
Experimental: Pregabalin XRDrug
Pregabalin XR: extended-release tablet, with an initial dose of 82.5 mg once daily. The dose may be adjusted every 7 days during the first 4 weeks of treatment, up to a maximum of 660 mg once daily. In addition, the experimental group will receive a placebo twice daily.
Comparator: Dorene TabsDrug
Pregabalin immediate-release tablets, at an initial dose of 75 mg twice daily. The dose may be adjusted every 7 days during the first 4 weeks of treatment, up to a maximum of 300 mg twice daily. In addition, the comparator group will receive a placebo once daily.
Comparator placeboDrug
Comparator placebo
experimental placeboDrug
experimental placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Difference in the mean pain intensity score 16 weeks after the start of treatment, compared to baselineTime frame: 16 weeks
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Cpec Obras Sociais Irmã Dulce
Salvador, Estado de Bahia, Brazil · Recruiting
Instituto Anima de Extensão Universitária - Unibh
Belo Horizonte, Minas Gerais, Brazil · Recruiting
Centro de Ensino Superior de Vespasiano
Vespasiano, Minas Gerais, Brazil · Recruiting
Instituto Estadual Do Cerebro Paulo Niemeyer
Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting
Apec Sociedade Potiguar de Educação E Cultura
Natal, Rio Grande do Norte, Brazil · Recruiting
Clinica Neurologica E Neurocirurgica de Joinville
Joinville, Santa Catarina, Brazil · Recruiting
Instituto Anima de Extensão Universitária - Unisul
Palhoça, Santa Catarina, Brazil · Recruiting
Casa de Nossa Senhora Da Paz Ação Social Franciscana
Bragança Paulista, São Paulo, Brazil · Recruiting
Synvia Campinas
Campinas, São Paulo, Brazil · Recruiting
Trialstar Campinas
Campinas, São Paulo, Brazil · Recruiting
Synvia Clinical Barra Funda
São Paulo, São Paulo, Brazil · Recruiting
Iscp Sociedade Educacional
São Paulo, São Paulo, Brazil · Recruiting
Fundação de Beneficência Hospital de Cirurgia
Aracaju, Sergipe, Brazil · Recruiting
Associação Aracajuana Hospital Santa Isabel
Aracaju, Sergipe, Brazil · Recruiting
Newdata Clinical Research
Aracaju, Sergipe, Brazil · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.